FDA-approved HIV drug reduces biological aging in healthy adults by 6+ years
This week's aging research brought some surprising discoveries—from an unexpected anti-aging effect of HIV medications to new insights into why our cells accumulate damage over time.
🎯 HIV Drug Shows Anti-Aging Effects in Healthy People
36 healthy adults (aged 18-50) who took emtricitabine-tenofovir-alafenamide (FTC/TAF) for 12 weeks showed significant reductions in biological aging markers
Their PhenoAge decreased by 6.33 years and DunedinPACE (a measure of aging pace) dropped by 0.061 points—both statistically significant improvements
The drug also reduced inflammatory markers, with IL-6 levels dropping significantly, while a similar HIV drug combination (FTC/TDF) showed no anti-aging effects
Why it matters: This is the first human evidence that certain HIV medications might slow aging by suppressing retrotransposons (jumping genes that become active with age). The specific formulation matters—TAF's better cellular penetration appears key to the anti-aging effect.
Key Findings
🧬 Senescent Cells Become More Common With Age Due to Cell Vulnerability
Researchers propose that cells become increasingly susceptible to entering senescence as they age, independent of immune system decline
This cell-intrinsic mechanism means that even with perfect immune clearance, senescent cells would still accumulate over time
The finding suggests that targeting senescent cells alone may not be enough—interventions need to address why cells become more vulnerable to senescence in the first place
🔬 AI Predicts Death Risk Using Blood Markers of Cellular Aging
Scientists developed a deep learning model using blood proteins to create a "SASP Score" that measures cellular senescence burden across the body
In UK Biobank participants, higher scores strongly predicted mortality risk and serious conditions like dementia, heart attacks, and strokes
Multimodal exercise significantly improved SASP Score trajectories over 18 months, suggesting lifestyle interventions can reduce cellular aging
🍅 Tomato Compound Improves Memory and Reduces Brain Aging in Mice
Tomatidine, found in tomatoes, reduced frailty and improved motor coordination and cognitive performance in aged mice
The compound decreased senescence markers (p16, p21) in liver, skin, and brain neurons while reducing neuroinflammation
Brain blood vessel integrity improved, with enhanced tight junction proteins suggesting better blood-brain barrier function
💊 Repurposed Cancer Drug Extends Lifespan by Targeting Fat Cell Aging
Homoharringtonine (HHT), an FDA-approved leukemia drug, selectively killed senescent fat cells while sparing healthy ones in screening of 2,150 compounds
Male mice treated with HHT showed improved metabolism, reduced fat tissue inflammation, and extended lifespan in both diet-induced obesity and natural aging models
The drug works by interacting with heat shock protein HSPA5, offering a new mechanism for targeting aging in fat tissue
🧠 Mitochondrial DNA Triggers Chronic Inflammation Through Immune Sensors
When mitochondrial DNA escapes into the cell's cytoplasm, it activates the cGAS-STING pathway, triggering inflammatory responses and cellular senescence
This mechanism is implicated in eye diseases, neurodegeneration, lung inflammation, heart disease, and oral health problems
The pathway represents a key link between mitochondrial dysfunction and age-related inflammatory diseases
🔬 Pregnancy History Linked to Slower Biological Aging in Large Study
Among 137,218 UK women, those with pregnancy history showed lower biological age and slower aging acceleration compared to those who never had children
Women with pregnancy history had KDM biological age 0.312 years lower and PhenoAge 0.242 years lower than never-pregnant women
Unhealthy lifestyle behaviors increased biological age regardless of pregnancy status, with no interaction between the two factors
Implications
This week's research reveals aging as a complex interplay between cellular vulnerability, mitochondrial dysfunction, and systemic inflammation. The promising anti-aging effects of repurposed drugs—from HIV medications to cancer treatments—suggest that existing therapies may offer unexpected longevity benefits, potentially accelerating the path to human anti-aging interventions.
Studies in this issue
Primary sources used for this newsletter.
- FDA-Approved Tenofovir Alafenamide Treatment May Lower Biological Age in Healthy Adults by Targeting Mobile DNA Elementsmain storymedRxiv : the preprint server for health sciences2026-04-03PMID 41929344
- Homoharringtonine may reduce obesity and insulin resistance linked to diet and aging and help mice live longerkey findingNature communications2026-03-31PMID 41916993
- How pregnancy history and unhealthy lifestyle relate to faster biological agingkey findingFrontiers in public health2026-04-02PMID 41923756
- Mitochondrial DNA may trigger inflammation through the cGAS-STING immune pathwaykey findingInflammation research : official journal of the European Histamine Research Society ... [et al.]2026-03-31PMID 41917448
- Tomatidine may improve thinking and reduce aging cells in old micekey findingEMBO molecular medicine2026-04-01PMID 41922652
- Basic Cell Process Behind Age-Related Build-Up of Old, Non-Dividing Cellskey findingAging and disease2026-03-30PMID 41910648
- Using deep learning to predict health risks and death from the body's level of aging cellskey findingmedRxiv : the preprint server for health sciences2026-04-03PMID 41929337
Continue reading
All Longevity & Aging issuesGet the next Longevity & Aging issue
Seven papers, once a week. Free.